Regulation of integrin surface expression

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/7105 (2006.01) A61K 31/713 (2006.01) C12N 15/11 (2006.01)

Patent

CA 2734863

Disclosed are methods and compositions for preventing and treating conditions associated with platelet aggregation, comprising administering a therapeutically effective amount of a composition that modifies the interaction of DNAJC10 with .alpha.11b.beta.3 in a megakaryocyte, thereby altering the expression of .alpha.11b.beta.3 on the surface of the megakaryocyte.

L'invention concerne des procédés et des compositions, pour empêcher et pour traiter les états associés à une agrégation plaquettaire, qui comportent l'administration d'une quantité thérapeutique efficace d'une composition qui modifie l'interaction de DNAJC10 avec a11bß3 dans un mégacaryocyte, modifiant ainsi l'expression de a11bß3 sur la surface du mégacaryocyte.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Regulation of integrin surface expression does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Regulation of integrin surface expression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Regulation of integrin surface expression will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1983850

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.